Comparative Pharmacology
Head-to-head clinical analysis: OSMITROL 10 IN WATER versus SORBITOL MANNITOL IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OSMITROL 10 IN WATER versus SORBITOL MANNITOL IN PLASTIC CONTAINER.
OSMITROL 10% IN WATER vs SORBITOL-MANNITOL IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into extracellular fluid and increasing renal blood flow, thereby enhancing water excretion.
Sorbitol and mannitol are osmotic diuretics. They increase osmotic pressure in the glomerular filtrate, reducing water reabsorption and promoting diuresis. Mannitol also decreases intracranial and intraocular pressure by creating an osmotic gradient that draws water from tissues into the vasculature.
0.25-2 g/kg intravenously over 30-60 minutes, repeated every 6-12 hours as needed. Maximum dose: 2 g/kg per dose or 200 g daily.
Intravenous infusion of 50 mL of a 25% sorbitol-25% mannitol solution administered over 10–20 minutes; may repeat once after 6–8 hours if needed.
None Documented
None Documented
Terminal elimination half-life is approximately 0.25–1.5 hours in patients with normal renal function, prolonged in renal impairment.
Sorbitol: approximately 0.5-1 hour; mannitol: approximately 0.5-1.5 hours. In anuria, mannitol half-life may extend to 36 hours.
Renal: >90% excreted unchanged by glomerular filtration with minimal tubular reabsorption. Negligible biliary/fecal elimination.
Renal: >95% as unchanged sorbitol and mannitol; negligible biliary/fecal elimination.
Category C
Category A/B
Osmotic Diuretic
Osmotic Diuretic